Drugs that contain Vancomycin
1. Vancomycin patents expiration
VANCOMYCIN's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11517609 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(11 years from now) | |
| US10039804 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(11 years from now) | |
| US10849956 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(11 years from now) | |
| US11000567 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(11 years from now) | |
| US10188697 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(11 years from now) | |
Market Authorisation Date: 26 August, 2021
Treatment: Method of treating bacterial infections
Dosage: SOLUTION;INTRAVENOUS, ORAL
More Information on Dosage
VANCOMYCIN family patents
